We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-8.14%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.56B
AUM Growth
-$1.36B
Cap. Flow
-$1.11B
Cap. Flow %
-31.07%
Top 10 Hldgs %
29.11%
Holding
1,521
New
512
Increased
155
Reduced
168
Closed
620

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$193M
2
AMZN icon
Amazon
AMZN
+$126M
3
AMD icon
Advanced Micro Devices
AMD
+$77.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$49.2M
5
XYZ
Block Inc
XYZ
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 2.48%
2 Consumer Discretionary 1.2%
3 Communication Services 1.16%
4 Technology 1.08%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVB
1476
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-250,000
Closed -$1.41M
SIOX
1477
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-500
Closed -$1K
FPAC
1478
CALL
DELISTED
Far Peak Acquisition Corporation
FPAC
-209,800
Closed -$2.11M
FPAC
1479
DELISTED
Far Peak Acquisition Corporation
FPAC
-100,000
Closed -$1.01M
LHDX
1480
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-30,000
Closed -$258K
TTM
1481
DELISTED
Tata Motors Limited
TTM
-2,500
Closed -$80K
TTM
1482
PUT
DELISTED
Tata Motors Limited
TTM
-35,000
Closed -$1.12M
CORZ
1483
CALL
DELISTED
Core Scientific, Inc. Common Stock
CORZ
-80,000
Closed -$876K
CLVS
1484
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-5,000
Closed -$14K
CLR
1485
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-9,500
Closed -$425K
CLR
1486
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-13,900
Closed -$622K
QTNT
1487
DELISTED
Quotient Limited Ordinary Shares
QTNT
-1,000
Closed -$59.8K
CCXI
1488
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
-16,300
Closed -$593K
CCXI
1489
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
-27,600
Closed -$1M
IEA
1490
PUT
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-17,200
Closed -$158K
GBT
1491
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
-15,000
Closed -$439K
GBT
1492
DELISTED
Global Blood Therapeutics, Inc.
GBT
-5,000
Closed -$146K
GBT
1493
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
-30,000
Closed -$878K
CHNG
1494
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-67,000
Closed -$1.43M
RDUS
1495
DELISTED
Radius Health, Inc.
RDUS
-5,000
Closed -$37.9K
PSTH
1496
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
-21,252
Closed -$421K
PSTH
1497
PUT
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
-50,000
Closed -$986K
CNR
1498
CALL
DELISTED
Cornerstone Building Brands, Inc.
CNR
-11,100
Closed -$194K
CERN
1499
CALL
DELISTED
Cerner Corp
CERN
-65,800
Closed -$6.11M
ZNGA
1500
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-563,500
Closed -$4.95M

Similar funds

SG3 Management's Q1 2022 Portfolio in Review

As of Q1 2022, SG3 Management held 1,521 positions worth $3.56B, down 28% from $4.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

SG3 Management withdrew a net $1.11B in Q1 2022, closing 620 positions and reducing 168 holdings. Its most notable exit was Tesla, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, SG3 Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $13.5M.

  • SG3 Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 30,000 shares worth $13.5M.
  • SG3 Management added most to Bausch Health in Q1 2022, an estimated $27.4M increase.
  • SG3 Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $126M.
  • SG3 Management fully exited Tesla in Q1 2022, selling an estimated $193M.
  • SG3 Management's ten largest holdings make up 29% of its $3.56B portfolio in Q1 2022.
  • SG3 Management opened 512 new positions and closed 620 in Q1 2022.
  • SG3 Management's portfolio value fell 28% quarter-over-quarter to $3.56B.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.